Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis
- PMID: 1684511
- DOI: 10.1016/0952-7915(91)90095-i
Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis
Abstract
The immunocytochemical demonstration, using monoclonal antibodies, of diverse cellular constituents has improved our understanding of many aspects of oncology. This review will focus on this approach to facilitate the detection of human tumors, improve their histological classification and provide functional parameters with potential aetiological, prognostic and/or therapeutic value.
Similar articles
-
c-erbB-2 gene product-like expression in urothelial carcinomas of the human bladder. Its value as a prognostic indicator in superficial tumors.Pathologica. 1991 Jul-Aug;83(1086):413-20. Pathologica. 1991. PMID: 1686491
-
The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.Year Immunol. 1993;7:182-92. Year Immunol. 1993. PMID: 8103950 Clinical Trial. No abstract available.
-
Application of monoclonal antibodies to tumor diagnosis and therapy.Ann Clin Lab Sci. 1983 May-Jun;13(3):173-84. Ann Clin Lab Sci. 1983. PMID: 6347022 Review.
-
Analysis of hybridoma-exchange antibodies.Hybridoma. 1982;1(4):461-3. doi: 10.1089/hyb.1.1982.1.461. Hybridoma. 1982. PMID: 6208140 No abstract available.
-
Monoclonal antibodies to oncogene products.Prog Clin Biol Res. 1989;288:35-52. Prog Clin Biol Res. 1989. PMID: 2654954 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources